A Review of Perindopril in the Reduction of Cardiovascular Events

References

• AsmarRGLondonGMO'RourkeMEImprovement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenololHypertension200138922611641310
   PubMed Web of Science ®Google Scholar
• BeeversGLipGYO'BrienEABC of hypertension: The pathophysiology of hypertensionBr Med J20013229121611302910
   PubMed Web of Science ®Google Scholar
• BijlstraPJSmitsPLuttermanJAEffect of long-term angiotensin-converting enzyme inhibition on endothelial function in patients with the insulin-resistance syndromeJ Cardiovasc Pharmacol199525658647596136
   PubMed Web of Science ®Google Scholar
• [BPLTT] Blood Pressure Lowering Treatment Trialists' CollaborationEffects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trialsArch Intern Med200516514101915983291
   PubMedGoogle Scholar
• [CAFE] The CAFE Investigators; for the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) investigatorsDifferential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) studyCirculation200611312132516476843
   PubMed Web of Science ®Google Scholar
• CampbellDJKladisADuncanAMEffects of converting enzyme inhibitors on angiotensin and bradykinin peptidesHypertension199423439498144213
   PubMed Web of Science ®Google Scholar
• ChobanianAVBakrisGLBlackHRSeventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension20034212065214656957
   PubMed Web of Science ®Google Scholar
• DahlofBDevereuxRBKjeldsenSECardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololLancet2002359995100311937178
   PubMed Web of Science ®Google Scholar
• DahlofBSeverPSPoulterNRPrevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trialLancet200536689590616154016
   PubMed Web of Science ®Google Scholar
• DalyCAFoxKMRemmeWJThe effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudyEur Heart J20052613697815860521
   PubMed Web of Science ®Google Scholar
• de LucaNMallionJMO'RourkeMFRegression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography studyAm J Hypertens200417660715323062
   PubMed Web of Science ®Google Scholar
• [EUROPA] European Trial on Reduction of Cardiac Events with Perindopril in Stable Coronary Artery Disease InvestigatorsEfficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)Lancet2003362782813678872
   PubMed Web of Science ®Google Scholar
• FerrariRPerindopril and Remodeling in Elderly with Acute Myocardial Infarction InvestigatorsEffects of angiotensin-converting enzyme inhibition with perindopril on left vascular remodeling and clinical outcome: results of the randomized Perindopril and Remodelling in Elderly with Acute Myocardial Infarction (PREAMI) studyArch Intern Med20061666596616567606
   PubMed Web of Science ®Google Scholar
• FlatherMDYusufSKoberLLong-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patientsLancet200035515758110821360
   PubMed Web of Science ®Google Scholar
• GuytonACHallJEColemanTGLaraghJHBrennerBMThe dominant role of the kidneys in long term arterial pressure regulation in normal and hypertensive statesHypertension: pathophysiology, diagnosis, and management1995New YorkRaven Pr Ltd131126
   Google Scholar
• HanssonLLindholmLHNiskanenLEffect of angiotensinconverting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trialLancet19993536111610030325
   PubMed Web of Science ®Google Scholar
• [HOPE] Heart Outcomes Prevention Evaluation Study InvestigatorsEffects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patientsN Engl J Med20003421455310639539
   PubMed Web of Science ®Google Scholar
• HuntSAAbrahamWTChinMHACC/AHA 2005 Guideline update for the diagnosis and management of chronic heart failure in the adult – summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm SocietyCirculation2005112182552
   Web of Science ®Google Scholar
• IkramMKWittemanJCMVingerlingJRRetinal vessel diameters and risk of hypertension: the Rotterdam studyHypertension2006471899416380526
   PubMed Web of Science ®Google Scholar
• JohnsonRJHerrera-AcostaJSchreinerGFSubtle acquired renal injury as a mechanism of salt-sensitive hypertensionN Engl J Med20023469132311907292
   PubMed Web of Science ®Google Scholar
• JuliusSKjeldsenSEWeberMOutcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trialLancet200436320223115207952
   PubMed Web of Science ®Google Scholar
• KeuperWVerheugtFWHotline sessions of the 27th European congress of cardiologyEur Heart J2005262596916246833
   PubMedGoogle Scholar
• KingDEEganBMMainousAG3rdElevation of C-reactive protein in people with prehypertensionJ Clin Hypertens (Greenwich)20046562815470285
   PubMedGoogle Scholar
• LandrayMJEdmundsELi-Saw-HeeFLAbnormal lowdensity lipoprotein subfraction profile in patients with untreated hypertensionQjm2002951657111865172
   PubMed Web of Science ®Google Scholar
• LewisEJHunsickerLGBainRPThe effect of angiotensinconverting-enzyme inhibition on diabetic nephropathyN Engl J Med19933291456628413456
   PubMed Web of Science ®Google Scholar
• LipGYBlannADBeeversDGProthrombotic factors, endothelial function and left ventricular hypertrophy in isolated systolic hypertension compared with systolic-diastolic hypertensionJ Hypertens1999171203710466477
   PubMed Web of Science ®Google Scholar
• LipGYBlannADZarifisJSoluble adhesion molecule Pselectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary reportJ Hypertens199513167488903631
   PubMed Web of Science ®Google Scholar
• MarkALStructural changes in resistance and capacitance vessels in borderline hypertensionHypertension19846Suppl IIIIII-69III-736394493
   PubMedGoogle Scholar
• MogensenCEVibertiGHalimiSEffect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIERHypertension20034110637112654706
   PubMed Web of Science ®Google Scholar
• NoonJPWalkerBRWebbDJImpaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressureJ Clin Invest199799187399109431
   PubMed Web of Science ®Google Scholar
• [PEACE] PEACE Trial InvestigatorsAngiotensin-convertingenzyme inhibition in stable coronary artery diseaseN Engl J Med200435120586815531767
   PubMed Web of Science ®Google Scholar
• PittBACE inhibitors for patients with vascular disease without left ventricular dysfunction—may they rest in PEACE?N Engl J Med200435121151715531768
   PubMed Web of Science ®Google Scholar
• PoulterNRWedelHDahlofBRole of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)Lancet20053669071316154017
   PubMed Web of Science ®Google Scholar
• [PROGRESS] PROGRESS Collaborative GroupRandomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attackLancet200135810334111589932
   PubMed Web of Science ®Google Scholar
• [PROGRESS] PROGRESS Collaborative GroupEffects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebro-vascular diseaseEur Heart J2003244758412633548
   PubMed Web of Science ®Google Scholar
• [PSC] Prospective Studies CollaborationAge-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesLancet200236019031312493255
   PubMed Web of Science ®Google Scholar
• RemmeWJSwedbergKGuidelines for the diagnosis and treatment of chronic heart failureEur Heart J20012215276011492984
   PubMed Web of Science ®Google Scholar
• SafarMEBoudierHSVascular development, pulse pressure, and the mechanisms of hypertensionHypertension200546205915911744
   PubMed Web of Science ®Google Scholar
• SimonGPathogenesis of structural vascular changes in hypertensionJ Hypertens20042231015106784
   PubMedGoogle Scholar
• SkovKMulvanyMJStructure of renal afferent arterioles in the pathogenesis of hypertensionActa Physiol Scand200418139740515283751
   PubMedGoogle Scholar
• WatanabeSTagawaTYamakawaKInhibition of the reninangiotensin system prevents free fatty acid-induced acute endothelial dysfunction in humansArterioscler Thromb Vasc Biol20052523768016179595
   PubMed Web of Science ®Google Scholar
• WeberMAJuliusSKjeldsenSEBlood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE TrialLancet200436320495115207957
   PubMed Web of Science ®Google Scholar
• [WHO] World Health OrganizationWorld Health Report 2002: reducing risks, promoting healthy life2002GenevaWHO
   Google Scholar
• WongTYShankarAKleinRProspective cohort study of retinal vessel diameters and risk of hypertensionBr Med J20043297915175230
   PubMed Web of Science ®Google Scholar
• Zandi-NejadKLuyckxVABrennerBMAdult hypertension and kidney disease. The role of fetal programmingHypertension200647502816415374
   PubMed Web of Science ®Google Scholar
• ZeitzCJCampbellDJHorowitzJDMyocardial uptake and biochemical and hemodynamic effects of ACE inhibitors in humansHypertension200341482712623947
   PubMed Web of Science ®Google Scholar